An important FDA program called "MedWatch" allows health care professionals and consumers to report serious problems that they believe may be associated with the medical products they prescribe, dispense, or use. These reports, along with follow-up investigations, can help to identify important safety concerns.
The second annual FDA Clinical Investigator Training Course, co-sponsored by the Food and Drug Administration's (FDA) Office of Critical Path Programs and the Clinical Trials Transformation Initiative (CTTI) will be held on November 8-10 at the National Labor College, Maryland.
Four Israeli institutions ranked among world's top universities. As in previous years, the study gives top grades to American universities, with just two European institutions in the top 10.
Israeli Growth Unexpectedly Accelerates to 4.7%. Israeli economic growth unexpectedly accelerated to an annualized 4.7 percent in the second quarter, its fastest pace in more than two years, as exports and consumer spending increased.
Israeli biopharmaceutical firm Kamada has entered into an exclusive distribution and manufacturing agreement with US company Baxter International for Kamada’s liquid, ready to use, intravenous alpha-1 antitrypsin product for the treatment of hereditary alpha-1 antitrypsin deficiency approved by the FDA on July 1, for marketing under the trade name Glassia.
 
The drug giant Novartis wants share of Israeli startup's products and will invest up to $670m in Israeli Quark biotech.
Israel’s Ministry of Health offers training on preparing and submitting medical device clinical trial applications.